Novartis | NVS - Los Ingresos Por Intereses





Los Ingresos Por Intereses Cambio Fecha
AbbVie USD 59M 13M 2025-12
AstraZeneca USD 73M 62M 2026-03
Bausch Health Companies USD 9M 6M 2025-12
Biogen USD 37.9M 700K 2026-03
Canopy Growth CAD 3.86M 1.89M 2026-03
Corcept Therapeutics USD 5.42M 399K 2025-12
Drreddys Laboratories INR 796M 332M 2025-12
Eli Lilly USD 65M 25M 2025-09
Gilead Sciences USD 95M 7M 2025-12
GlaxoSmithKline GBP 22M 96M 2026-03
Glaxosmithkline GBP 22M 4M 2026-03
J&J USD 2.14 237M 2026-03
Merck USD 69M 27M 2025-12
Pacira USD 2.3M 6.24M 2025-12
Pfizer USD 115M 51M 2026-03
Phibro Animal Health USD 0.08 0.09 2024-12
Sanofi EUR 33M 81M 2025-12
Sanofi EUR 60M 54M 2026-03
Supernus Pharmaceuticals USD 2.02M 254K 2025-12
Zoetis USD 25M 1000K 2025-12